Ayahuasca and cancer treatment

SAGE Open Medicine
Eduardo Ekman Schenberg

Abstract

Comprehensively review the evidence regarding the use of ayahuasca, an Amerindian medicine traditionally used to treat many different illnesses and diseases, to treat some types of cancer. An in-depth review of the literature was conducted using PubMed, books, institutional magazines, conferences and online texts in nonprofessional sources regarding the biomedical knowledge about ayahuasca in general with a specific focus in its possible relations to the treatment of cancer. At least nine case reports regarding the use of ayahuasca in the treatment of prostate, brain, ovarian, uterine, stomach, breast, and colon cancers were found. Several of these were considered improvements, one case was considered worse, and one case was rated as difficult to evaluate. A theoretical model is presented which explains these effects at the cellular, molecular, and psychosocial levels. Particular attention is given to ayahuasca's pharmacological effects through the activity of N,N-dimethyltryptamine at intracellular sigma-1 receptors. The effects of other components of ayahuasca, such as harmine, tetrahydroharmine, and harmaline, are also considered. The proposed model, based on the molecular and cellular biology of ayahuasca's known active com...Continue Reading

References

Jan 17, 1969·Science·R E Schultes
Mar 17, 1971·Nature: New Biology·A J Mandell, M Morgan
Jan 1, 1981·International Review of Neurobiology·S A BarkerS T Christian
Mar 1, 1980·Psychosomatics·O C SimontonT F Sparks
Oct 1, 1995·Mutation Research·C de Meester
Feb 1, 1996·The Journal of Nervous and Mental Disease·C S GrobK B Boone
Nov 14, 1997·Mutation Research·J N PicadaJ A Henriques
Oct 13, 1998·Pharmacology, Biochemistry, and Behavior·R L SmithE Sanders-Bush
Jul 15, 1999·Journal of Ethnopharmacology·J C CallawayD C Mash
Sep 7, 2001·Drug and Alcohol Dependence·S M HusbandsA L Hudson
Mar 22, 2002·The Lancet Oncology·A J Vickers, B R Cassileth
Oct 4, 2002·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·Mercedes YritiaManel J Barbanoj
Feb 5, 2003·The American Psychologist·Stanley C Krippner
Mar 28, 2003·The Journal of Pharmacology and Experimental Therapeutics·Jordi RibaManel J Barbanoj
Apr 20, 2004·Journal of Neurology, Neurosurgery, and Psychiatry·L F CalladoJ J Meana
Dec 21, 2004·International Journal of Cancer. Journal International Du Cancer·Qi ChenAnlong Xu
Jan 15, 2005·Psycho-oncology·Liz RoffeEdzard Ernst
Sep 10, 2005·Journal of Psychoactive Drugs·Evelyn Doering-SilveiraDartiu X Da Silveira
Sep 10, 2005·Journal of Psychoactive Drugs·Dartiu Xavier Da SilveiraEvelyn Doering-Silveira
Sep 10, 2005·Journal of Psychoactive Drugs·Marlene Dobkin de RiosEvelyn Doering-Silveira
Sep 10, 2005·Journal of Psychoactive Drugs·Evelyn Doering-SilveiraDartiu Xavier Da Silveira
Sep 10, 2005·Journal of Psychoactive Drugs·J C Callaway
Sep 10, 2005·Journal of Psychoactive Drugs·Michael Winkelman
Sep 10, 2005·Journal of Psychoactive Drugs·Jordi Riba, Manel J Barbanoj
Sep 17, 2005·Journal of Bioenergetics and Biomembranes·Ludivine Walter, György Hajnóczky
Oct 18, 2005·Biochimica Et Biophysica Acta·Antonio ToninelloBruno Mondovì
Nov 24, 2006·The Journal of Biological Chemistry·Adrien RenaudoOlivier Soriani
Feb 3, 2007·Current Pharmaceutical Design·Thomas Lee CollierMichael Kassiou
Feb 21, 2008·Journal of Neurochemistry·Harald Sontheimer
Apr 24, 2008·Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Für Toxikologische Pathologie·Judith JiménezRosario Rodríguez-Arnaiz
Jul 3, 2008·Journal of Psychopharmacology·Mw JohnsonRr Griffiths
Jul 22, 2008·The International Journal on Drug Policy·Kenneth W Tupper
Aug 30, 2008·The Journal of Pharmacology and Experimental Therapeutics·Yelenis HerreraJavier Cuevas
Sep 9, 2008·Explore : the Journal of Science and Healing·Jeff Levin
Oct 29, 2008·CNS Spectrums·Stephen M Stahl, Angela Felker

❮ Previous
Next ❯

Citations

Mar 15, 2016·Frontiers in Pharmacology·Ede FrecskaMichael Winkelman
Jan 1, 2015·Molecular & Cellular Oncology·P Fernández-MartínezP Sánchez-Gómez
Nov 30, 2018·Environmental and Molecular Mutagenesis·Fábio KummrowAlessandra Linardi
Aug 31, 2018·Journal of Psychoactive Drugs·Miroslav HorákNahanga Verter
Dec 9, 2020·Journal of Psychoactive Drugs·Lucas Oliveira MaiaLuís Fernando Tófoli

❮ Previous
Next ❯

Methods Mentioned

BETA
irradiating

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.